MYOM3-AS1

Across TCGA pan-cancer cohorts, MYOM3-AS1 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated MYOM3-AS1 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher MYOM3-AS1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MYOM3-AS1 expression acts as an unfavorable survival marker, although some lineages such as KIRP and READ show a favorable association.

MESO, LUAD, and THCA are the cancer types where MYOM3-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	All	0.228	0.588	<.001	108	view →
LUAD	OS	Tertile	III,IV	0.222	0.672	.001	48	view →
THCA	DFS	Tertile	III,IV	0.691	0.908	.006	39	view →
UCS	DFS	Tertile	IV	0.132	0.718	.002	36	view →
LIHC	OS	Tertile	III,IV	0.092	0.615	<.001	36	view →
PRAD	OS	Tertile	All	0.939	0.995	.004	30	view →
KIRP	OS	Quartile	II,III,IV	0.844	0.559	.009	19	view →
BLCA	OS	Tertile	IV	0.147	0.587	.018	18	view →
HNSC	OS	Tertile	III,IV	0.292	0.575	.024	18	view →
SKCM	OS	Tertile	II,III,IV	0.422	0.739	.001	15	view →
GBM	DFS	Tertile	All	0.089	0.258	.041	9	view →
LUSC	DFS	Tertile	All	0.289	0.399	.042	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

MYOM3-AS1–MESO (OS)

Open the MESO breakdown →